Cytotoxic T Cells (cd8 ) - Vaccines

Relevant Publications

Cataloging circulating CD3CD56 T cells through a series of stimulating (NKG2D, DNAM-1) and inhibitory (PD-1, TIGIT, and Tim-3) immune checkpoint receptors in women diagnosed with precancerous cervical lesions or invasive cervical carcinoma.

Issue Release: 2024

Identification and validation of tumor-specific T cell receptors from tumor infiltrating lymphocytes using tumor organoid co-cultures.

Issue Release: 2024

BRD7 as key factor in PBAF complex assembly and CD8+ T cell differentiation.

Issue Release: 2024

Cholestasis-induced phenotypic transformation of neutrophils contributes to immune escape of colorectal cancer liver metastasis.

Issue Release: 2024

Inhibiting the NADase CD38 improves cytomegalovirus-specific CD8+ T cell functionality and metabolism.

Issue Release: 2024

Limited HIV-associated neuropathologies and lack of immune activation in sub-saharan African individuals with late-stage subtype C HIV-1 infection.

Issue Release: 2024

Cancer stem cell-derived exosomes in CD8 T cell exhaustion.

Issue Release: 2024

Nanoparticle-mediated celastrol ER targeting delivery amplify immunogenic cell death in melanoma.

Issue Release: 2024

Injectable hybrid hydrogels enable enhanced combination chemotherapy and roused anti-tumor immunity in the synergistic treatment of pancreatic ductal adenocarcinoma.

Issue Release: 2024

Biomimetic gold nanocages incorporating copper-human serum albumin for tumor immunotherapy via cuproptosis-lactate regulation.

Issue Release: 2024

Identification of pediatric activated T-cell hepatitis using clinical immune studies.

Issue Release: 2024

Copper(II)-Based Nano-Regulator Correlates Cuproptosis Burst and Sequential Immunogenic Cell Death for Synergistic Cancer Immunotherapy.

Issue Release: 2024

Type I conventional dendritic cells facilitate immunotherapy in pancreatic cancer.

Issue Release: 2024

Chemokines and Cytokines in Immunotherapy of Melanoma and Other Tumors: From Biomarkers to Therapeutic Targets.

Issue Release: 2024

Tumor microenvironment reprogramming improves nanomedicine-based chemo-immunotherapy in sarcomas.

Issue Release: 2024

Genetics of Macrophage Activation Syndrome in Systemic Juvenile Idiopathic Arthritis.

Issue Release: 2024

Distinct granzyme k expression in immune cells: a single-cell rna-seq meta-analysis.

Issue Release: 2024

CD8 T Cell Biology in Cytokine Storm Syndromes.

Issue Release: 2024

Establishment of a protocol for rapidly expanding Epstein-Barr-virus-specific cytotoxic T cells with enhanced cytotoxicity.

Issue Release: 2024

Lck Function and Modulation: Immune Cytotoxic Response and Tumor Treatment More Than a Simple Event.

Issue Release: 2024

Why is Transparency Important in Vaccine Reporting?

Which Vaccines Have Shown to Lower Hospitalization Rates?

What is Glycemic Control?

What is Vaccine Misinformation?

How is Acyclovir Administered?

How does the VSD ensure data privacy and security?

What are Plasmodium Parasites?

Are There Any Challenges with Using Telemedicine for Vaccination?

How Can Vaccine Hesitancy Be Addressed?

Which Vaccines are Recommended During Pregnancy?

Partnered Content Networks

Relevant Topics